3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Anemia, Refractory, with Excess of Blasts
24
Myelodysplastic Syndromes
23
Leukemia, Lymphocytic, Chronic, B-Cell
21
Leukemia, Myelomonocytic, Chronic
20
Hodgkin Disease
19
Myeloproliferative Disorders
18
Multiple Myeloma
16
Lymphoma, Non-Hodgkin
16
Leukemia
15
Primary Myelofibrosis
14
Lymphoma
14
Congenital Abnormalities
14
Anemia, Aplastic
14
Lymphoma, Follicular
13
Leukemia, Myeloid, Chronic-Phase
13
Leukemia, Myeloid, Accelerated Phase
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Burkitt Lymphoma
11
Lymphoma, B-Cell, Marginal Zone
10
Neoplasms, Plasma Cell
9
Myelodysplastic-Myeloproliferative Diseases
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, Large B-Cell, Diffuse
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Graft vs Host Disease
9
Polycythemia Vera
8
Blast Crisis
8
Interventions
apixaban
22
Rivaroxaban
16
Dalteparin
16
Enoxaparin
11
Heparin, Low-Molecular-Weight
10
Tinzaparin
8
Aspirin
8
Fondaparinux
4
Dabigatran
4
edoxaban
3
Warfarin
3
Nadroparin
3
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Observation
2
MAA868
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
calcium heparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Tacrolimus
×
Classical hematology
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled